NewLink Genetics intends to price public offering of its common shares

Bookrunners Jefferies and Stifel Nicolaus Weisel have greenshoe

By Devika Patel

Knoxville, Tenn., Jan. 29 - NewLink Genetics Corp. will price a public offering of common stock with a 30-day greenshoe, according to a preliminary prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Stine Seed Farm, Inc., an existing stockholder, has indicated it might buy $12 million of the shares.

Jefferies & Co., Inc. and Stifel, Nicolaus & Co., Inc. are the joint bookrunning managers.

Proceeds will be used for general corporate purposes, including regulatory, clinical trial, research and development, general and administrative and manufacturing expenses.

The biopharmaceutical company is based in Ames, Iowa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.